Duchenne Muscular Dystrophy clinical trials at UCSF
2 in progress, 0 open to eligible people
Showing trials for
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
Sorry, in progress, not accepting new patients
This study is a long-term study of ataluren in participants with nonsense mutation Duchenne muscular dystrophy.
Oakland, California and other locations
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Sorry, in progress, not accepting new patients
This is a Phase 2, open-label, single arm trial of pamrevlumab (FG-3019) to estimate pamrevlumab's safety and efficacy in non-ambulatory subjects with DMD.
San Francisco, California and other locations
Last updated: